In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria.
AUTOR(ES)
Huovinen, P
RESUMO
The in vitro activity of LY146032, a novel cyclic lipopeptide antibiotic, was tested against different gram-positive clinical isolates. The activity of LY146032 was clearly higher than that of vancomycin against all isolates tested. However, in some instances rifampin and imipenem showed higher activity than did LY146032.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174751Documentos Relacionados
- In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
- In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
- In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria.
- In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.
- In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide.
